TREATMENT OF FRAGILE X SYNDROME WITH CANNABIDIOL

The present technology relates to a method of treating one or more behavioral symptoms of Fragile X Syndrome in a subject by transdermally administering an effective amount of cannabidiol (CBD) to the subject wherein one or more behavioral symptoms of Fragile X Syndrome are treated in the subject. L...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	BONN-MILLER Marcel, TICH Nancy, MESSENHEIMER John, GUTTERMAN Donna, SEBREE Terri
Format:	Patent
Sprache:	eng ; spa
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present technology relates to a method of treating one or more behavioral symptoms of Fragile X Syndrome in a subject by transdermally administering an effective amount of cannabidiol (CBD) to the subject wherein one or more behavioral symptoms of Fragile X Syndrome are treated in the subject. La presente tecnología se refiere a un método de tratamiento de uno o más síntomas de conducta del síndrome del cromosoma X frágil en un sujeto, mediante la administración transdérmica de una cantidad eficaz de canabidiol (CBD) al sujeto, con lo que son tratados en el sujeto uno o más síntomas de conducta del síndrome del cromosoma X frágil.